Uppsala, Sweden

Doxa Ab

USPTO Granted Patents = 10

% Expired Patents = 40.0


Trademarks = 1

Forward Citations = 33

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Leif Hermansson (10 out of 21 patents)

silverMedal Håkan Engqvist (7 out of 9 patents)

bronzeMedal Jesper Lööf (3 out of 3 patents)

4.  Emil Abrahamsson (2 out of 2 patents)

5.  Niklas Axén (1 out of 12 patents)

6.  Per-Olof Glantz (1 out of 1 patent)

7.  Nils-Otto Ahnfelt (1 out of 2 patents)

8.  Jesper Loof (1 out of 1 patent)

9.  Lars Kraft (1 out of 5 patents)

10.  Jan-Erik Schulz-Walz (1 out of 1 patent)

11.  Dan Markusson (1 out of 4 patents)

12.  Tobias Persson (1 out of 3 patents)

13.  Erik Johansson (5 patents)

14.  Niklas Axen (5 patents)

15.  Kajsa Björklund (2 patents)


10 patents:

Company Overview
Doxa Ab is a technology-driven company based in Uppsala, Sweden, specializing in advanced solutions for the medical device sector. The organization focuses on the development and manufacturing of innovative products that enhance patient care and streamline healthcare processes. With a commitment to research and development, Doxa Ab leverages cutting-edge technologies to address complex challenges in medical diagnostics and treatment, positioning itself as a key player in the evolving landscape of healthcare technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#33 in Uppsala

#594 in Sweden

#56,092 in the World

Uppsala, SE
Uppsala, Sweden
Forward Citations = 33

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Doxa Ab. Retrieved from https://idiyas.com/company/doxa-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…